Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Mink Therapeutics Inc (INKT)

  • Technical Exchange News
  • March 01, 2024, 18:47 UTC
  • 37
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Eterna Therapeutics Inc (ERNA)

  • Technical Exchange News
  • March 01, 2024, 18:47 UTC
  • 36
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Entera Bio Ltd. (ENTX)

  • Technical Exchange News
  • March 01, 2024, 18:47 UTC
  • 37
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Precision BioSciences (DTIL)

  • Technical Exchange News
  • March 01, 2024, 18:47 UTC
  • 36
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Jin Medical International Ltd (ZJYL)

  • Technical Exchange News
  • Feb. 29, 2024, 20:30 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Delinquent.

Comment Full text

Passage Bio Inc (PASG)

  • Technical Exchange News
  • Feb. 29, 2024, 20:30 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Jin Medical International Ltd (ZJYL)

  • Technical Exchange News
  • Feb. 29, 2024, 20:29 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Delinquent.

Comment Full text

Passage Bio Inc (PASG)

  • Technical Exchange News
  • Feb. 29, 2024, 20:29 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Aileron Therapeutics Inc. (ALRN)

  • Technical Exchange News
  • Feb. 29, 2024, 20:29 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Aclarion Inc (ACON)

  • Technical Exchange News
  • Feb. 29, 2024, 20:29 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 771
  • 772
  • 773
  • 774
  • 775
  • Next

Search

News categories

  • Technical Exchange News(11963)
  • Event(4938)
  • SEC News(246241)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(148403)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin